Cart
sales@molnova.com
Mofebutazone
CAS No. 2210-63-1
Mofebutazone( —— )
Catalog No. M20940 CAS No. 2210-63-1
Mofebutazone inhibits the immunological release of prostaglandins as well as leukotrienes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 54 | Get Quote |
|
| 25MG | 93 | Get Quote |
|
| 50MG | 146 | Get Quote |
|
| 100MG | 219 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMofebutazone
-
NoteResearch use only, not for human use.
-
Brief DescriptionMofebutazone inhibits the immunological release of prostaglandins as well as leukotrienes.
-
DescriptionMofebutazone inhibits the immunological release of prostaglandins as well as leukotrienes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2210-63-1
-
Formula Weight232.28
-
Molecular FormulaC13H16N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCC1C(=O)NN(c2ccccc2)C1=O
-
Chemical Name35-Pyrazolidinedione 4-butyl-1-phenyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.J Neumüller Tohidast-Akrad M . Comparative in vitro investigations of the influence of mofebutazone phenylbutazone and diclofenac on phagocytosis and respiratory burst of human peripheral blood leucocytes[J]. Arzneimittelforschung 1994 44(5):636-641.
molnova catalog
related products
-
BCAT-IN-2
BCAT-IN-2 is an orally active and selective inhibitor of mitochondrial branched-chain aminotransferase (BCATm), inhibits BCATm and BCATc, and is used in obesity and dyslipidemia.
-
Urolignoside
Urolignoside shows antioxidant and radical scavenging activity.
-
Psalmotoxin 1
Psalmotoxin 1 is a potent and selective acid-sensing ion channel 1a (ASIC1a) blocker.
